In Russia, lutetium-177 is used to treat neuroendocrine tumors for the first time
22 March 2024
The Federal State Budgetary Institution Scientific Research Center for Radiology of the Ministry of Health of Russia has successfully utilized a Russian radiopharmaceutical drug based on lutetium-177 to treat patients with metastatic and inoperable neuroendocrine tumors for the first time. Both patients were diagnosed with a neuroendocrine tumor of the pancreas, progressing against the background of standard chemotherapy.
In 2023, Russia has registered 540 drugs
22 March 2024
In 2023, the Russian Ministry of Health registered a total of 540 medicines, with less than half, specifically 160 (29.6%), being of foreign origin. This was stated by the head of the department, Mikhail Murashko, emphasizing that “Russian pharma has begun to create innovative products.”
In Russia, regulatory requirements for the development of biotechnological drugs may be reduced
21 March 2024
Participants of the BRICS working group gathered in Mumbai, India, to delve into the study of competition in pharmaceutical markets. The discussion revolved around the proposal made by the Federal Antimonopoly Service (FAS) to revise regulatory requirements with the aim of boosting the competitiveness of new biosimilar drugs. As part of this discussion, the idea was also put forward to develop proposals to reduce barriers to access biological medicines in the BRICS markets and to create common regulatory instruments.
Parkinson’s infusion treatment demonstrates advantage over oral delivery
21 March 2024
Delivering the traditional Parkinson’s treatment via subcutaneous infusion over a 24-hour period was shown to be safe and effective, research found.
Mycoplasma testing market expected to value nearly $2 million by 2031 Technology innova
20 March 2024
Technology innovations and a stronger focus on developing novel drugs to treat chronic diseases, are key drivers for the global mycoplasma testing market up to the next decade, research states. According to research published by Coherent Market Insights, the global mycoplasma testing market is anticipated to reach $1,907.6 million by 2031.
By 2030, 150 new chemical enterprises will be created in Russia
20 March 2024
The Minister of Industry and Trade of the Russian Federation, Denis Manturov, announced during a meeting with President Vladimir Putin and members of the Cabinet of Ministers that approximately 150 new medium- and low-tonnage chemical enterprises will be established in Russia by 2030. Manturov stressed that, following the president’s orders, the development of the most crucial sectors for the economy is being shifted to the framework of national projects.
Innovative method could offer cost-effective sterilisation approach
19 March 2024
The new sterilisation method could provide an affordable, rapid approach for preparing microbiological culture media, research suggests.
In 2023, Russia has registered 540 drugs
19 March 2024
In 2023, the Russian Ministry of Health registered a total of 540 medicines, with less than half, specifically 160 (29.6%), being of foreign origin. This was stated by the head of the department, Mikhail Murashko, emphasizing that “Russian pharma has begun to create innovative products.”
Rapid pseudomonas aeruginosa detection method developed
18 March 2024
Research suggests the rapid detection method “will enable the timely implementation of microbiological monitoring strategies for large batches of medications”.
Health Ministry has approved a drug for the treatment of Niemann–Pick disease
18 March 2024
The Ministry of Health of the Russian Federation issued a regulatory certificate to the Dutch company Genzyme Europe (Genzyme has been owned by Sanofi since 2011) for the drug Zenpozyme (olipudase alfa), intended for the treatment of a rare genetic disease – Niemann-Pick disease A/B and B types. In 2023, this disease was included in the roster of conditions entitling individuals to receive treatment funded by the “Circle of Kindness” state fund.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russia has expanded the mandatory health insurance program for 2024-2026
29 March 2024
Russian scientists have developed new TB vaccines for both injection and nasal administration.
29 March 2024
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024